Results 1 to 10 of about 495 (105)

Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case

open access: goldResearch and Practice in Thrombosis and Haemostasis, 2021
Afibrinogenemia and congenital dysfibrinogenemia (CD) are rare conditions with limited information available for appropriate management. Previous case reports have demonstrated the safe and efficacious use of fibrinogen replacement therapy (FRT) as a ...
Megan Langer   +5 more
doaj   +2 more sources

Multidisciplinary team management of congenital dysfibrinogenemia in pregnancy: a case report [PDF]

open access: goldBMC Pregnancy and Childbirth
Background Congenital dysfibrinogenemia is a rare autosomal dominant disorder involving abnormal fibrinogen function, leading to variable risks of bleeding and thrombosis.
Meng Jie He   +3 more
doaj   +2 more sources

Spinal anesthesia in a patient with hereditary dysfibrinogenemia who underwent emergency cesarean delivery: a case report [PDF]

open access: goldJA Clinical Reports
Background Dysfibrinogenemia causes abnormal fibrinogen production, leading to thrombotic or bleeding complications, which are relative contraindications for neuraxial anesthesia.
Sae Ono   +6 more
doaj   +2 more sources

Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain [PDF]

open access: goldHaematologica, 2007
Disorders of fibrinogen are usually caused by genetic mutations that result in low protein levels (hypofibrinogenemia) or an abnormal molecule (dysfibrinogenemia). However, environmental and plasma factors can have an acquired effect on its expression or
A. Dear   +4 more
doaj   +2 more sources

“No End Point Detected”: A Unique Coagulation Profile Unmasking Dysfibrinogenemia

open access: yesCase Reports in Hematology
Dysfibrinogenemia is a rare qualitative fibrinogen disorder that can present with bleeding, thrombosis, or both. We report a case of a young woman with first-trimester pregnancy loss and severe hemorrhage, whose coagulation tests reported “no end point ...
Kelsey Uminski, Xiu Yan Jiang
doaj   +2 more sources

Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia

open access: goldHaematologica
In thrombosis and haemostasis, coagulation and platelet activation pathways culminate to form solid fibrin clots, which can become vaso-occlusive or prevent excessive bleeding.
Siyu Sun   +19 more
doaj   +2 more sources

Management and outcomes of women with low fibrinogen concentration during pregnancy or immediately postpartum: A UK national population‐based cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica
Introduction Pregnant women with a fibrinogen level
Caroline Diguisto   +5 more
doaj   +2 more sources

PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.

open access: goldHemaSphere, 2023
Amaury Monard   +12 more
doaj   +2 more sources

Young girl with congenital hypo-dysfibrogenemia presenting with an acute subdural haemorrhage

open access: yesAsian Journal of Internal Medicine, 2023
Fibrinogen plays a pivotal role in the coagulation cascade. Inherited fibrinogen disorders are a heterogenous group that includes lack or reduced fibrinogen levels or a qualitative disorder of fibrinogen, dysfibrinogenemia.
I. N. Walmsley   +3 more
doaj   +1 more source

Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report

open access: diamondTurkish Journal of Hematology, 2017
Şencan Acar   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy